Lv1
80 积分 2023-07-29 加入
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma
2小时前
待确认
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
4小时前
已完结
Single-cell analysis of advanced prostate cancer
2个月前
已完结
Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicity
2个月前
已完结
Biomarker Utilization for Regulatory Decision Making: A Landscape Analysis of Neurological Drug Products Approved by FDA (2008–2024)
2个月前
已完结
Targeting the tumour cell surface in advanced prostate cancer
2个月前
已完结
A First‐In‐Human Phase 1 Study of a Novel BCMA×CD3 Bispecific T Cell Engager EMB‐06 in Relapsed or Refractory Multiple Myeloma
2个月前
已完结
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
2个月前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
2个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
皖公网安备34019202002308
